| Symbol | ALVOW |
|---|---|
| Name | ALVOTECH |
| Sector | HEALTH CARE |
| Region | Europe |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 9, RUE DE BITBOURG, LUXEMBOURG, L-1273, Luxembourg |
| Telephone | +352 4224500 |
| Fax | — |
| — | |
| Website | https://www.alvotech.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001898416 |
| Description | Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases. Additional info from NASDAQ: |
Alvotech further strengthens liquidity by securing term loan facility of $75 million
Read moreAlvotech further strengthens liquidity by securing term loan facility of $75 million
Read moreAlvotech further strengthens liquidity by securing term loan facility of $75 million
Read moreAlvotech styrkir lausafjárstöðu sína enn frekar með aðgengi að 75 milljóna dala lánsfjármögnun
Read moreNew Form SCHEDULE 13D/A - Alvotech <b>Filed:</b> 2026-06-30 <b>AccNo:</b> 0001213900-26-073903 <b>Size:</b> 1 MB
Read more